2/26
04:14 pm
abcl
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
Low
Report
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
2/25
12:14 am
abcl
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
2/24
06:47 pm
abcl
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
2/24
04:05 pm
abcl
AbCellera Reports Full Year 2025 Business Results
Medium
Report
AbCellera Reports Full Year 2025 Business Results
2/14
01:32 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
2/11
04:05 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
Medium
Report
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
2/5
11:07 am
abcl
Short sales on the TSX: Where are the sellers as software stocks tumble? [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Short sales on the TSX: Where are the sellers as software stocks tumble? [Globe and Mail, The (Toronto, Canada)]
2/2
07:54 pm
abcl
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
1/30
01:42 am
abcl
Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop [Yahoo! Finance]
Medium
Report
Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop [Yahoo! Finance]
1/22
04:05 pm
abcl
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
Medium
Report
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
1/20
01:25 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
1/14
08:21 pm
abcl
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 [Yahoo! Finance]
Medium
Report
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 [Yahoo! Finance]
1/12
09:26 am
abcl
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause [Yahoo! Finance]
Low
Report
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause [Yahoo! Finance]
1/12
09:00 am
abcl
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
Low
Report
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
1/12
01:05 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
1/4
01:06 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Low
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
12/27
01:05 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at
Wall Stree
12/25
07:00 pm
abcl
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn [Yahoo! Finance]
Medium
Report
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn [Yahoo! Finance]
12/18
09:00 am
abcl
AbCellera and Bruker Reach Global Settlement of Patent Litigation
Low
Report
AbCellera and Bruker Reach Global Settlement of Patent Litigation
12/8
04:05 pm
abcl
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Low
Report
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
12/4
10:20 pm
abcl
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]